AU1890488A - Cyanuric acid derivatives - Google Patents

Cyanuric acid derivatives

Info

Publication number
AU1890488A
AU1890488A AU18904/88A AU1890488A AU1890488A AU 1890488 A AU1890488 A AU 1890488A AU 18904/88 A AU18904/88 A AU 18904/88A AU 1890488 A AU1890488 A AU 1890488A AU 1890488 A AU1890488 A AU 1890488A
Authority
AU
Australia
Prior art keywords
acid derivatives
cyanuric acid
cyanuric
derivatives
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU18904/88A
Inventor
Not Given Name
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of AU1890488A publication Critical patent/AU1890488A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/30—Only oxygen atoms
    • C07D251/34—Cyanuric or isocyanuric esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/38—Sulfur atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
AU18904/88A 1984-03-09 1988-07-08 Cyanuric acid derivatives Abandoned AU1890488A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19843408768 DE3408768A1 (en) 1984-03-09 1984-03-09 IMMUNTIMULATING AGENTS
DE3408768 1984-03-09

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU39480/85A Division AU573786B2 (en) 1984-03-09 1985-03-04 1-phenyl-1,3,5-triazine-2,4,6-trione derivatives

Publications (1)

Publication Number Publication Date
AU1890488A true AU1890488A (en) 1988-11-03

Family

ID=6230072

Family Applications (2)

Application Number Title Priority Date Filing Date
AU39480/85A Ceased AU573786B2 (en) 1984-03-09 1985-03-04 1-phenyl-1,3,5-triazine-2,4,6-trione derivatives
AU18904/88A Abandoned AU1890488A (en) 1984-03-09 1988-07-08 Cyanuric acid derivatives

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU39480/85A Ceased AU573786B2 (en) 1984-03-09 1985-03-04 1-phenyl-1,3,5-triazine-2,4,6-trione derivatives

Country Status (8)

Country Link
EP (1) EP0158075A1 (en)
JP (1) JPS60208915A (en)
AU (2) AU573786B2 (en)
CA (1) CA1249516A (en)
DE (1) DE3408768A1 (en)
HU (1) HU201677B (en)
IL (1) IL74520A (en)
ZA (1) ZA851752B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU606266B2 (en) * 1988-02-24 1991-01-31 Bayer Animal Health Gmbh Substituted 1,2,4-triazinediones, processes for their preparation and their use

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3703103A1 (en) * 1987-02-03 1988-08-11 Bayer Ag AGENT AGAINST FISH PARSITES
DE3703105A1 (en) * 1987-02-03 1988-08-11 Bayer Ag MEDICINE AGAINST PROTOCOES IN INSECTS
DE4228000A1 (en) * 1992-08-24 1994-03-03 Bayer Ag 3-aryl-triazine-2,4-diones
US5976580A (en) * 1995-06-07 1999-11-02 Novus International, Inc. Nutrient formulation and process for enhancing the health, livability, cumulative weight gain or feed efficiency in poultry and other animals
EP0971720A1 (en) * 1997-04-02 2000-01-19 Bioniche Inc. Use of bacterial cell wall extracts for treating topical disorders and wounds
EP1250152B1 (en) 1999-12-28 2013-05-15 Bioniche Urology IP Inc. Synergistic composition containing hyaluronic acid in the treatment of cancer
DE10040110A1 (en) * 2000-08-17 2002-02-28 Bayer Ag Use of triazinetrione sulfoxides to combat coccidioses
CN103694185B (en) * 2013-12-18 2016-02-17 湖北龙翔药业有限公司 The preparation method of toltrazuril an alkali metal salt
HUE061751T2 (en) * 2018-02-26 2023-08-28 AlzeCure Pharma AB Triazine derivatives for treating diseases relating to neurotrophins
GB201810669D0 (en) 2018-06-28 2018-08-15 Stiftelsen Alzecure New compounds
GB201810668D0 (en) 2018-06-28 2018-08-15 Stiftelsen Alzecure New compounds

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2413722C3 (en) * 1974-03-21 1982-04-08 Bayer Ag, 5090 Leverkusen New 1- (4-phenoxyphenyl) -1,3,5-triazine derivatives, a process for their preparation and their use as pharmaceuticals
DE2650014A1 (en) * 1976-10-30 1978-05-03 Bayer Ag 1- (4-PHENOXY-PHENYL) -1,3,5-TRIAZINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS A MEDICINAL PRODUCT
DE2718799A1 (en) * 1977-04-27 1978-11-09 Bayer Ag 1- (4-PHENOXY-PHENYL) -1,3,5-TRIAZINE DERIVATIVES, THE METHOD FOR THEIR MANUFACTURING AND THEIR USE AS A MEDICINAL PRODUCT AND GROWTH PROMOTER
DE3300793A1 (en) * 1983-01-12 1984-07-12 Bayer Ag, 5090 Leverkusen Coccidiosis
DE3314739A1 (en) * 1983-04-23 1984-10-25 Bayer Ag, 5090 Leverkusen 1- (4- (4- (FLUORALKYLMETHYLTHIO- OR -SULFINYL- OR -SULFONYL-) PHENOXY) PHENYL) -1,3,5-TRIAZINE-2,4,6 (1H, 3H, 5H) -TRIONE, PROCEDURE TO THEIR PRODUCTION AND USE AS COCCIDIOS
DE3405241A1 (en) * 1984-02-15 1985-08-29 Bayer Ag, 5090 Leverkusen 1- / 4- (BENZOTHIA- OR -OXAZOL-2-YLTHIO- OR -2-YLOXY) PHENYL / -1,3,5-TRIAZINE-2,4,6- (1H, 3H, 5H) -TRIONE, METHOD FOR THEIR PRODUCTION AND USE AS A MEDICINAL PRODUCT

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU606266B2 (en) * 1988-02-24 1991-01-31 Bayer Animal Health Gmbh Substituted 1,2,4-triazinediones, processes for their preparation and their use

Also Published As

Publication number Publication date
HU201677B (en) 1990-12-28
ZA851752B (en) 1985-11-27
DE3408768A1 (en) 1985-09-12
HUT37605A (en) 1986-01-23
AU3948085A (en) 1985-09-12
AU573786B2 (en) 1988-06-23
EP0158075A1 (en) 1985-10-16
IL74520A (en) 1988-06-30
CA1249516A (en) 1989-01-31
JPS60208915A (en) 1985-10-21
IL74520A0 (en) 1985-06-30

Similar Documents

Publication Publication Date Title
AU1117788A (en) Benzoxazone derivatives
AU4982185A (en) Novel 5-amino-4-hydroxyvaleryl derivatives
AU4263685A (en) Ammotetralin derivatives
AU4325485A (en) Aminoalkylphenoxy derivatives
AU5123285A (en) 2-piperizino-pteridine derivatives
AU571721B2 (en) Substituted propargyloxyacetonitrile derivatives
AU5131685A (en) Aminoacyllabdane derivatives
AU4738185A (en) Carbamoylimidazole derivatives
AU583281B2 (en) Thiobarbituric acid derivatives
AU1890488A (en) Cyanuric acid derivatives
AU4086885A (en) Hydroxy-4-2h-1-benzothiopyran-2-one derivatives
AU4343885A (en) Indole - tetrahydropyridyl derivatives
AU3797485A (en) Azolyl-aryl-alkanol derivatives
AU5088485A (en) 1-phenylimidazole-5-carboxylic acid derivatives
AU4145285A (en) Tetrahydroquinolin-1-yl- carbonylimidazole derivatives
AU552119B2 (en) 2-oxindole-1-carboxamide derivatives
AU4901285A (en) 2 - cyanobenzimidazole derivatives
AU577419B2 (en) Ascorbic acid derivatives
AU576877B2 (en) Apovincaminic acid derivatives
AU4106085A (en) 2 - oxoindole derivatives
AU4045585A (en) Sulphamoylguanidine derivatives
AU581931B2 (en) Fungicidal propenic acid derivatives
AU4702285A (en) Amino acid derivatives
ZA853995B (en) Substituted phenoxyphenylpropionic acid derivatives
AU3977285A (en) Carboxyalkyldipeptide derivatives